Fluent Financial’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-8,749
Closed -$725K 74
2022
Q4
$725K Sell
8,749
-15,871
-64% -$1.26M 0.43% 45
2022
Q3
$1.75M Buy
24,620
+1,856
+8% +$160K 0.96% 41
2022
Q2
$1.97M Buy
22,764
+1,412
+7% +$132K 1.01% 34
2022
Q1
$2.31M Buy
+21,352
New +$2.2M 0.95% 38

Other funds holding TECH

Fluent Financial's TECH Position: Q1 2023 in Review

Fluent Financial sold out of Bio-Techne (TECH) in Q1 2023, closing a stake of 8,749 shares — an estimated $725K sold.

Fluent Financial first reported a position in TECH in Q1 2022 and held it in 4 quarters. The position peaked at $2.31M in Q1 2022. 550 funds tracked by Wall St. Rank hold TECH as of Q1 2023.

  • Fluent Financial reported no remaining Bio-Techne position as of Q1 2023 after selling out during the quarter.
  • Fluent Financial sold 8,749 Bio-Techne shares in Q1 2023, an estimated $725K.
  • Fluent Financial first reported a position in Bio-Techne in Q1 2022 and held it in 4 quarters.
  • Fluent Financial's Bio-Techne position peaked at $2.31M in Q1 2022.
  • 550 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2023.

Based on Fluent Financial's 13F filing for Q1 2023, filed 11 May 2023.